0001062993-23-018392.txt : 20230921
0001062993-23-018392.hdr.sgml : 20230921
20230921203212
ACCESSION NUMBER: 0001062993-23-018392
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230815
FILED AS OF DATE: 20230921
DATE AS OF CHANGE: 20230921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRETHLEIN ANDREW J
CENTRAL INDEX KEY: 0001270921
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-20859
FILM NUMBER: 231270059
MAIL ADDRESS:
STREET 1: 651 GATEWAY BLVD STE 950
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GERON CORP
CENTRAL INDEX KEY: 0000886744
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 752287752
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 919 EAST HILLSDALE BOULEVARD
STREET 2: SUITE 250
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6504737700
MAIL ADDRESS:
STREET 1: 919 EAST HILLSDALE BOULEVARD
STREET 2: SUITE 250
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
FORMER COMPANY:
FORMER CONFORMED NAME: GERON CORPORATION
DATE OF NAME CHANGE: 19960521
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-08-15
0000886744
GERON CORP
GERN
0001270921
GRETHLEIN ANDREW J
C/O GERON CORPORATION
919 E. HILLSDALE BLVD, SUITE 250
FOSTER CITY
CA
94404
0
1
0
0
EVP, Chief Operating Officer
0
Employee Stock Option (right to buy)
1.72
2023-08-15
4
A
0
221544
0
A
2023-08-15
2028-11-06
Common Stock
221544
221544
D
Performance-based stock option granted on November 7, 2018 and vested in full on August 15, 2023 upon acceptance of the NDA by the
US FDA for imetelstat in lower risk MDS.
/s/ Olivia Bloom for Andrew J. Grethlein
2023-09-21